Amy Hantes
Obstetrics & Gynecology · Rockwall, TXNPI 1306042569
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $849 and has fallen 62.5% since, to $318 in 2025.
Across 130 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$382
- AbbVie$337
- Millicent US Inc$315
- Sumitomo Pharma America, Inc.$279
- Exeltis, USA Inc.$177
- Pfizer$142
- plus $958 from 19 others
What the payments were for
- Food & beverage$2,50497%
- Education$873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $382 |
| AbbVie | 17 | $337 |
| Millicent US Inc | 16 | $315 |
| Sumitomo Pharma America, Inc. | 25 | $279 |
| Exeltis, USA Inc. | 10 | $177 |
| Pfizer | 6 | $142 |
| Agile Therapeutics, Inc. | 6 | $123 |
| Mayne Pharma Commercial LLC | 4 | $92 |
| Therapeuticsmd, Inc. | 5 | $79 |
| Shield Therapeutics Inc | 1 | $78 |
| Johnson & Johnson | 3 | $70 |
| Axonics, Inc. | 3 | $62 |
| Avion Pharmaceuticals | 4 | $60 |
| Medtronic | 2 | $46 |
| Myovant Sciences Inc. | 3 | $44 |
| Bayer | 2 | $41 |
| Hologic Sales And Service, LLC | 1 | $39 |
| BD | 2 | $35 |
| Aspira Women's Health Inc | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Baxter Healthcare | 1 | $29 |
| Chiesi USA, Inc. | 1 | $28 |
| Evofem Biosciences, Inc. | 1 | $25 |
| Exact Sciences | 1 | $23 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$122
How this compares
$2,591 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 68 | $2,427 |
| ProgesteroneProgesterone, Micronized | 28 | $1,994 |
| LyllanaEstradiol | 12 | $1,558 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $269 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Rockwall
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.